Two Sigma Investments’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-597
Closed -$5.46K 3358
2023
Q3
$5.46K Sell
597
-810
-58% -$7.41K ﹤0.01% 2835
2023
Q2
$29.7K Sell
1,407
-793
-36% -$16.7K ﹤0.01% 2799
2023
Q1
$59.2K Sell
2,200
-7,411
-77% -$199K ﹤0.01% 2652
2022
Q4
$340K Buy
9,611
+7,924
+470% +$281K ﹤0.01% 2136
2022
Q3
$381K Sell
1,687
-378
-18% -$85.4K ﹤0.01% 1846
2022
Q2
$390K Buy
2,065
+1,162
+129% +$219K ﹤0.01% 1852
2022
Q1
$225K Buy
+903
New +$225K ﹤0.01% 2268
2021
Q4
Sell
-901
Closed -$181K 3255
2021
Q3
$181K Sell
901
-233
-21% -$46.8K ﹤0.01% 2328
2021
Q2
$290K Sell
1,134
-4,805
-81% -$1.23M ﹤0.01% 2139
2021
Q1
$1.58M Sell
5,939
-2,162
-27% -$574K ﹤0.01% 1377
2020
Q4
$2.99M Sell
8,101
-1,215
-13% -$448K 0.01% 917
2020
Q3
$2.28M Buy
9,316
+1,899
+26% +$464K 0.01% 872
2020
Q2
$2.14M Buy
7,417
+367
+5% +$106K 0.01% 849
2020
Q1
$1.44M Buy
7,050
+3,735
+113% +$762K 0.01% 808
2019
Q4
$1.48M Buy
3,315
+2,478
+296% +$1.11M ﹤0.01% 1232
2019
Q3
$257K Sell
837
-1,744
-68% -$535K ﹤0.01% 1682
2019
Q2
$821K Sell
2,581
-96
-4% -$30.5K ﹤0.01% 1426
2019
Q1
$1.12M Buy
2,677
+1,322
+98% +$555K ﹤0.01% 1381
2018
Q4
$413K Buy
1,355
+524
+63% +$160K ﹤0.01% 1640
2018
Q3
$299K Buy
831
+44
+6% +$15.8K ﹤0.01% 1751
2018
Q2
$288K Buy
+787
New +$288K ﹤0.01% 1795
2016
Q1
Sell
-188
Closed -$125K 2423
2015
Q4
$125K Buy
188
+51
+37% +$33.9K ﹤0.01% 1916
2015
Q3
$65K Sell
137
-243
-64% -$115K ﹤0.01% 1574
2015
Q2
$215K Buy
380
+218
+135% +$123K ﹤0.01% 2002
2015
Q1
$1.38M Buy
162
+112
+224% +$955K 0.01% 1241
2014
Q4
$442K Buy
+50
New +$442K ﹤0.01% 1782